Skip to main content
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1999 Aug;123(1):165–175. doi: 10.1017/s0950268899002666

An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species.

A Vos 1, A Neubert 1, O Aylan 1, P Schuster 1, E Pommerening 1, T Müller 1, D C Chivatsi 1
PMCID: PMC2810740  PMID: 10487653

Abstract

SAD B19 is an attenuated vaccine virus for oral vaccination of carnivores against rabies. The safety of SAD B19 was investigated in 16 animal species by different routes of administration. During the observation period all animals given the vaccine virus, irrespective of the route of administration, did not show any clinical signs of rabies, with the exception of certain rodent species. In these animals a low residual pathogenicity was observed, however transmission of the vaccine virus to control animals was not demonstrable. No vaccine virus could be detected in the saliva of the six mammal species examined. Furthermore, the genetical stability was shown for SAD B19 through passaging in neural tissue of dogs, foxes and mice. From the results presented here on innocuity and stability, it can be concluded that SAD B19 rabies vaccine is suitable for oral vaccination campaigns for carnivores against rabies.

Full Text

The Full Text of this article is available as a PDF (188.9 KB).


Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES